Skip to main content
. 2017 May 18;16(3):240–251. doi: 10.1002/rmb2.12037

Table 4.

Usage and pregnancy or conception rates of the cryopreserved semen of patients with cancer and patients with testicular cancer (TC)

Authors Year of study report Patients who cryopreserved sperm (N) Patients who used sperm for ART (N) Usage rate (%) Patients who used sperm with available data (N) Patients who succeeded (N) Success rate in pregnancy/paternity (%)
Studies on male patients with cancer overall
Ragni et al.101
2003
686 36 5.2 28 10 36a
Ishikawa et al.102
2007
118 4 3.4 4 2 50a
van Casteren et al.103
2008
557 42 7.5 37 18 49a
Bizet et al.104
2012
931 57 6.1 47 22 47a
Botchan et al.105
2013
682 70 10.3 68 27 40a
Studies on patients with TC
Spermon et al.46
2003
78 13 16.7 13 7 54b
Magelssen et al.31
2005
422 29 6.9 29 16 55 b
Brydøy et al.43
2005
326 59 18.1 59 18 31 b
Sonnenburg et al.10
2015
61 11 18.0 11 9 82 b

ART, assisted reproductive technology. aPregnancy rate; bPaternity rate.